Vehicle composition influence on the microneedle-enhanced transdermal flux of naltrexone hydrochloride

Pharmaceutical Research

Volumn 28, Issue 1, 2011, Pages 124-134

  Milewski, Mikolaj ^a   Stinchcomb, Audra L ^a  

^a University of Kentucky   (United States)

Author keywords

microneedles; naltrexone hydrochloride; propylene glycol; transdermal drug delivery; viscosity

Indexed keywords

NALTREXONE; PROPYLENE GLYCOL; WATER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; IN VITRO STUDY; MICRONEEDLE; NEEDLE; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; STRATUM CORNEUM; VISCOSITY;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CARRIERS; INJECTIONS, INTRADERMAL; MICROINJECTIONS; MODELS, BIOLOGICAL; NALTREXONE; NARCOTIC ANTAGONISTS; NEEDLES; PROPYLENE GLYCOL; SKIN; SKIN ABSORPTION; SOLUBILITY; SWINE; SWINE, MINIATURE; VISCOSITY; WATER;

EID: 78651254362     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-010-0191-x     Document Type: Article

References (49)

1. GL Flynn 2002 Cutaneous and transdermal delivery-processes and systems of delivery Drugs Pharm Sci 121 187 235 1:CAS:528:DC%2BD38XnvVSmsbg%3D
2. MR Prausnitz S Mitragotri R Langer 2004 Current status and future potential of transdermal drug delivery Nat Rev Drug Discov 3 115 124 1:CAS:528:DC%2BD2cXhtlartbg%3D 10.1038/nrd1304 15040576 (Pubitemid 38239773)
3. MR Prausnitz R Langer 2008 Transdermal drug delivery Nat Biotechnol 26 1261 1268 1:CAS:528:DC%2BD1cXhtlCktrrF 10.1038/nbt.1504 18997767
4. S Henry DV McAllister MG Allen MR Prausnitz 1998 Microfabricated microneedles: a novel approach to transdermal drug delivery J Pharm Sci 87 922 925 1:CAS:528:DyaK1cXkvVGktrw%3D 10.1021/js980042+ 9687334 (Pubitemid 28381247)
5. DV McAllister PM Wang SP Davis J-H Park PJ Canatella MG Allen MR Prausnitz 2003 Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies Proc Natl Acad Sci USA 100 13755 13760 1:CAS:528:DC%2BD3sXpsFGisrw%3D 10.1073/pnas.2331316100 14623977 (Pubitemid 37499139)
6. SA Coulman D Barrow A Anstey C Gateley A Morrissey N Wilke C Allender K Brain JC Birchall 2006 Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles Curr Drug Deliv 3 65 75 1:CAS:528: DC%2BD28XktlCisA%3D%3D 10.2174/156720106775197510 16472095
7. SL Banks RR Pinninti HS Gill PA Crooks MR Prausnitz AL Stinchcomb 2008 Flux across microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro Pharm Res 25 1677 1685 1:CAS:528: DC%2BD1cXmslWmsrs%3D 10.1007/s11095-008-9578-3 18449628
8. JR Volpicelli KC Rhines JS Rhines LA Volpicelli AI Alterman CP O'Brien 1997 Naltrexone and alcohol dependence. Role of subject compliance Arch Gen Psychiatry 54 737 742 1:CAS:528:DyaK2sXls1ygtrc%3D 9283509
9. MC Meyer AB Straughn MW Lo WL Schary CC Whitney 1984 Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration J Clin Psychiatry 45 15 19 1:CAS:528:DyaL2cXmt1ajsb4%3D 6469932
10. ME Wall DR Brine M Perez-Reyes 1981 Metabolism and disposition of naltrexone in man after oral and intravenous administration Drug Metab Dispos 9 369 375 1:CAS:528:DyaL3MXlt1Grs78%3D 6114837
11. Vivitrol website. http://www.vivitrol.com/hcp/Vivitrol-Info/adherence. aspx.
12. KS Paudel BN Nalluri DC Hammell S Valiveti P Kiptoo MO Hamad PA Crooks AL Stinchcomb 2005 Transdermal delivery of naltrexone and its active metabolite 6-beta-naltrexol in human skin in vitro and guinea pigs in vivo J Pharm Sci 94 1965 1975 1:CAS:528:DC%2BD2MXpslOgtL4%3D 10.1002/jps.20398 16052561 (Pubitemid 41554146)
13. AL Stinchcomb PW Swaan O Ekabo KK Harris J Browe DC Hammell TA Cooperman M Pearsall 2002 Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin J Pharm Sci 91 2571 2578 1:CAS:528:DC%2BD38XptVeksbw%3D 10.1002/jps.10239 12434400 (Pubitemid 35379414)
14. HK Vaddi MO Hamad J Chen SL Banks PA Crooks AL Stinchcomb 2005 Human skin permeation of branched-chain 3-O-alkyl ester and carbonate prodrugs of naltrexone Pharm Res 22 758 765 1:CAS:528:DC%2BD2MXkt1Omsrg%3D 10.1007/s11095-005-2592-9 15906171 (Pubitemid 40768588)
15. HK Vaddi SL Banks J Chen DC Hammell PA Crooks AL Stinchcomb 2009 Human skin permeation of 3-O-alkyl carbamate prodrugs of naltrexone J Pharm Sci 98 2611 2625 1:CAS:528:DC%2BD1MXns1eqsbw%3D 10.1002/jps.21594 18972573
16. DP Wermeling SL Banks DA Hudson HS Gill J Gupta MR Prausnitz AL Stichcomb 2008 Microneedles permit transdermal delivery of a skin-impermeant medication to humans Proc Natl Acad Sci USA 105 2058 2063 1:CAS:528:DC%2BD1cXisVWmsbg%3D 10.1073/pnas.0710355105 18250310 (Pubitemid 351439464)
17. Y Qiu Y Gao K Hu F Li 2008 Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes J Control Release 129 144 150 1:CAS:528:DC%2BD1cXnsFaltbc%3D 10.1016/j.jconrel.2008.04.019 18538885
18. MM Badran J Kuntsche A Fahr 2009 Skin penetration enhancement by a microneedle device (Dermaroller) in vitro: dependency on needle size and applied formulation Eur J Pharm Sci 36 511 523 1:CAS:528:DC%2BD1MXhs1aqur4%3D 10.1016/j.ejps.2008.12.008 19146954
19. DW Osborne JJ Heneke 1997 Skin penetration enhancers cited in the technical literature Pharm Technol 21 58 66
20. T Higuchi 1960 Physical chemical analysis of percutaneous absorption process from creams and ointments J Soc Cosmet Chem 11 85 97
21. BW Barry 1987 Mode of action of penetration enhancers in human skin J Control Release 6 85 97 1:CAS:528:DyaL1cXotF2rsw%3D%3D 10.1016/0168-3659(87) 90066-6 (Pubitemid 18017724)
22. M Goodman BW Barry 1988 Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique J Invest Dermatol 91 323 327 1:CAS:528: DyaL1cXmtFGrurg%3D 10.1111/1523-1747.ep12475655 3171212
23. NA Megrab AC Williams BW Barry 1995 Estradiol permeation through human skin and silastic membrane: effects of propylene glycol and supersaturation J Control Release 36 277 294 1:CAS:528:DyaK2MXosVOgtLc%3D 10.1016/0168-3659(95) 00062-D
24. L Trottet C Merly M Mirza J Hadgraft AF Davis 2004 Effect of finite doses of propylene glycol on enhancement of in vitro percutaneous permeation of loperamide hydrochloride Int J Pharm 274 213 219 1:CAS:528:DC%2BD2cXivFGksLg%3D 10.1016/j.ijpharm.2004.01.013 15072797 (Pubitemid 38457020)
25. C Herkenne A Naik YN Kalia J Hadgraft RH Guy 2007 Effect of propylene glycol on ibuprofen absorption into human skin in vivo J Pharm Sci 97 185 197 10.1002/jps.20829
26. RM Watkinson RH Guy J Hadgraft ME Lane 2009 Optimisation of cosolvent concentration for topical drug delivery-II: influence of propylene glycol on ibuprofen permeation Skin Pharmacol Physiol 22 225 230 1:CAS:528: DC%2BD1MXhtFOhsbfK 10.1159/000231528 19648784
27. Gill HS, Prausnitz MR. Coated microneedles for transdermal delivery. J Controlled Release. 2007;117(2):227-37.
28. MA Hussain CA Koval MJ Myers EG Shami E Shefter 1987 Improvement of the oral bioavailability of naltrexone in dogs: a prodrug approach J Pharm Sci 76 356 358 1:CAS:528:DyaL2sXlt1SqtLw%3D 10.1002/jps.2600760503 3656096
29. WR Lieband WD Stein 1969 Biological membranes behave as nonporous polymeric sheets with respect to the diffusion of nonelectrolytes Nature (London, United Kingdom) 224 240 243 10.1038/224240a0
30. JM Diamond Y Katz 1974 Interpretation of nonelectrolyte partition coefficients between dimyristoyl lecithin and water J Membr Biol 17 121 154 1:CAS:528:DyaE2cXkvVKqu7c%3D 10.1007/BF01870176 4407798
31. Kasting GB, Smith RL, Anderson BD. Prodrugs for dermal delivery: solubility, molecular size, and functional group effects. In: Sloan KB, editor. Prodrugs: topical and ocular drug delivery. New York, USA: Marcel Dekker; 1992. p. 117-61.
32. Potts RO, Guy RH. Predicting skin permeability. Pharm Res. 1992;9:663-9.
33. AS Michaels SK Chandrasekaran JE Shaw 1975 Drug permeation through human skin. Theory and in vitro experimental measurement AIChE J 21 985 996 1:CAS:528:DyaE2MXlvVyitbg%3D 10.1002/aic.690210522
34. WJ Albery J Hadgraft 1979 Percutaneous absorption: in vivo experiments J Pharm Pharmacol 31 140 147 1:CAS:528:DyaE1MXltFOqurs%3D 34686
35. K Tojo 1987 Random brick model for drug transport across stratum corneum J Pharm Sci 76 889 891 1:CAS:528:DyaL1cXkvVKqtQ%3D%3D 10.1002/jps.2600760208 3440932 (Pubitemid 17043677)
36. DA Edwards R Langer 1994 A linear theory of transdermal transport phenomena J Pharm Sci 83 1315 1334 1:CAS:528:DyaK2cXlsVWls74%3D 10.1002/jps.2600830925 7830250
37. ME Johnson D Blankschtein R Langer 1997 Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism J Pharm Sci 86 1162 1172 1:CAS:528:DyaK2sXlvVygsLs%3D 10.1021/js960198e 9344175 (Pubitemid 27430923)
38. Talreja PS, Kasting GB, Kleene NK, Pickens WL, Wang T-F. Visualization of the lipid barrier and measurement of lipid pathlength in human stratum corneum. PharmSci [online computer file]. 3:No pp given; 2001.
39. HF Frasch AM Barbero 2003 Steady-state flux and lag time in the stratum corneum lipid pathway: results from finite element models J Pharm Sci 92 2196 2207 1:CAS:528:DC%2BD3sXovFCrs7o%3D 10.1002/jps.10466 14603505 (Pubitemid 37356693)
40. Flynn GL. Cutaneous and transdermal delivery: processes and systems of delivery. In: Rhodes CT, Banker GS, editors. Modern pharmaceutics. New York: Marcel Dekker; 1990. p. 239-98.
41. JD Bos MMHM Meinardi 2000 The 500 Dalton rule for the skin penetration of chemical compounds and drugs Exp Dermatol 9 165 169 1:CAS:528: DC%2BD3cXjvVWitLw%3D 10.1034/j.1600-0625.2000.009003165.x 10839713 (Pubitemid 30255378)
42. M Meidan 2004 Emerging technologies in transdermal therapeutics Am J Ther 11 312 316 10.1097/01.mjt.0000101826.94820.6b 15266225
43. GL Flynn SH Yalkowsky TJ Roseman 1974 Mass transport phenomena and models. Theoretical concepts J Pharm Sci 63 479 510 1:CAS:528:DyaE2cXksVKnsLg%3D 10.1002/jps.2600630403 4828694
44. K Kretsos B Kasting Gerald 2007 A geometrical model of dermal capillary clearance Math Biosci 208 430 453 10.1016/j.mbs.2006.10.012 17303187 (Pubitemid 47101854)
45. M Sznitowska B Berner HI Maibach 1993 In vitro permeation of human skin by multipolar ions Int J Pharm 99 43 49 1:CAS:528:DyaK3sXms1Wqt7k%3D 10.1016/0378-5173(93)90321-6 (Pubitemid 23276361)
46. JA Cordero L Alarcon E Escribano R Obach J Domenech 1997 A comparative study of the transdermal penetration of a series of nonsteroidal antiinflammatory drugs J Pharm Sci 86 503 508 1:CAS:528:DyaK2sXhslagurs%3D 10.1021/js950346l 9109056 (Pubitemid 27154769)
47. J Hadgraft C Valenta 2000 pH, pKa and dermal delivery Int J Pharm 200 243 247 1:CAS:528:DC%2BD3cXktFemsrc%3D 10.1016/S0378-5173(00)00402-6 10867254 (Pubitemid 30364911)
48. JJ Kaufman NM Semo WS Koski 1975 Microelectrometric titration measurement of the pKa's and partition and drug distribution coefficients of narcotics and narcotic antagonists and their pH and temperature dependence J Med Chem 18 647 655 1:CAS:528:DyaE2MXltVylsrY%3D 10.1021/jm00241a001 239235
49. K Sugano N Takata M Machida K Saitoh K Terada 2002 Prediction of passive intestinal absorption using bio-mimetic artificial membrane permeation assay and the paracellular pathway model Int J Pharm 241 241 251 1:CAS:528: DC%2BD38XkvFelt74%3D 10.1016/S0378-5173(02)00240-5 12100852 (Pubitemid 34718026)